Featuring Gowns by:
Bottega Veneta Veneta Bucket-body Bag
About MetaStat, Inc.
metastatic disease in all epithelial based solid tumors. Both the MetaSite BreastTM and MenaCalcTM product lines are designed to accurately stratify patients based Bottega Veneta Intrecciato Leather Chest Pocket Wallet
speed and growth of a tumor. A 60 person breast cancer study revealed that individuals with tumors with higher density of 'pumps' were more likely to develop metastasis in other organs.
Healing By Feces: Rise Of The DIY Gut Bug Swap, Nature Reveals Older Migraine Sufferers More Likely To Have Silent Strokes, University Of Miami Miller School Of Medicine Study
Dr. Heiner Dreismann, head of diagnostics at MetaStat and former president and chief executive officer of Roche Molecular Systems with more than 24 years of experience in the health care industry commented, "We believe that our novel diagnostic technologies based on our unique understanding of systemic metastasis will offer an early and reliable prediction and treatment of metastasis in patients with breast cancer and other solid tumors. Our MetaSite BreastTM test has the potential to allow women and their doctors to tailor and personalize a treatment approach that is most appropriate to their needs regarding chemotherapy."
MONTCLAIR, NJ / ACCESSWIRE / May 16, 2014 / MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today that our company was featured in an article titled, "Cancer caught in the act" written by Nature, a scientific journal highlighting the increased use of Intravital imaging used in research to monitor tumor cells as well as the growth, spread (metastasis) and treatment of cancer in living animal cells.
Amount Of Vitamin A During Pregnancy Affects Offspring Immunity, Nature Reveals Depressed Preschool Teachers Linked To Kids' Behavioral Problems, Ohio State University Study
MetaStat is a life sciences company that develops and commercialized diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis, the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body. MetaStat is focused on breast, prostate, lung and colorectal cancers, where systemic metastasis is responsible for approximately 90% of all deaths. The Company's function based diagnostic platform technology is based on the identification and understanding of the pivotal role of the mena protein and its isoforms, a common pathway for the development of systemic Balenciaga Belted Shoulder Bag
MetaStat Featured In Prestigious Scientific Journal Nature
on their individual risk of metastasis and to allow clinicians to better "customize" cancer treatment decisions by positively identifying patients with a high risk of metastasis who need aggressive therapy and by sparing patients with a low risk of metastasis from the harmful side effects and expense of chemotherapy. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10 K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward looking statements included herein, and not place undue reliance on such statements. The forward looking statements in this release are made as of the date hereof and the company undertakes no obligation to update such statements.
MetaStat has licensed this "pump" or MetaSite BreastTM technology and is using it both independently and in combination with our other diagnostic products, to develop tests that predict metastatic risk in women with breast cancer. Our MetaSite BreastTM test is the first diagnostic that directly detects and quantifies the actual mechanisms by which mestastatic cells disseminate through the blood stream to cause the secondary (metastatic) tumors that are responsible for 90% of fatalities in epithelial based sold tumor cancers. Over 600 women have already been studied employing this technology and additional clinical trials are expected to begin by the end of this calendar year Bottega Veneta Veneta Bucket-body Bag with anticipated commercialization in 2015.
Advances in Intravital imaging has given researchers the ability to use molecular markers to visualize eight different kinds of cells and structures, including immune system cells and endothelial cells that line blood vessels. The Intravital imaging revealed unusual cellular behavior in macrophages, an immune cell that usually removes dead cells, engulfs pathogens, stimulates immune response to fight cancer but can also boost the Guess Bag Pink Flowers
MetaStat Announces Exclusive Worldwide License Agreements For The Alternative Splicing Program In The Epithelial To Mesenchymal Transition (EMT) In Epithelial Cancers Could Birth Control Pills, Breastfeeding Reduce Risk Of Ovarian Cancer? University of Pennsylvania Study
Help employers find you! Check out all the .
Bottega Veneta Veneta Bucket-body Bag
New Balance U410cb
Balenciaga Giant City Bag Grey
Guess Leather Laptop Bag
Bottega Veneta Black And Gold Clutch
New Balance Ct300 Made In England
Balenciaga Giant 12 Gold City Bag
New Balance 420 Womens Burgundy
Balenciaga Part Time
Bottega Veneta Cervo Large Hobo
Bottega Veneta Crossbody Sale
Bottega Veneta Iphone 6 Plus Cover
New Balance 990 Grey
Guess Alivia Quilted Cross-body Bag
New Balance 574 Grey & Pink Trainers
Balenciaga City Bag Large